Skip to main content

Table 1 Summary of clinicopathological features in each case of sessile serrated adenoma/polyp (SSA/P) with dysplasia and invasive adenocarcinoma

From: Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study

Case No.

Age

Sex

Location

Macroscopic type

Size (mm)

Histological type

Depth of invasion (μm)

Mucinous component

Lymphatic invasion

Vascular invasion

Lymph node metastasis

Removal method

1

67

F

A

Sessile

10

HGD

Mucosa

–

–

–

–

EMR

2

69

M

S

Semipedunculated

10

HGD

Mucosa

–

–

–

–

EMR

3

79

F

C

Sessile

14

HGD

Mucosa

–

–

–

–

EMR

4

61

F

A

Sessile

18

HGD

Mucosa

–

–

–

–

ESD

5

61

M

D

Sessile

31

Well-ACA

Submucosa (400)

–

–

–

–

ESD + OPE

6

75

F

A

Sessile

15

Well-ACA

Submucosa (1100)

–

–

–

–

EMR + OPE

7

73

F

A

Sessile

25

Mod-ACA

Submucosa (2000)

–

+

–

+

OPE

8

65

F

T

Sessile

19

Mod-ACA

Submucosa (4000)

+

–

–

–

OPE

  1. M Male, F Female, C Cecum, A Ascending colon, T Transverse colon, D Descending colon, S Sigmoid colon, HGD High-grade dysplasia, Well-ACA Well-differentiated adenocarcinoma, Mod-ACA Moderately-differentiated adenocarcinoma, EMR Endoscopic mucosal resection, ESD Endoscopic submucosal dissection, OPE Operation, + present; − absent